Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q4 FY2014 Earnings Presentation
23 slides from Apollo Hospitals Enterprise's earnings presentation, 2014
Slide 1: Q4 FY 2014 Earnings Update
Bre IHUCHING LIVER Q4 FY 2014 Earnings Update
Slide 2: Safe Harbour
Safe Harbour No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the
Slide 3: Contents
Contents • Highlights • Standalone Financial Performance • Consolidated Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs 3
Slide 4: Highlights – (1/2) Financial Performance
Highlights – (1/2) FY14 Consolidated Revenues of Rs. 43,842 mio (up 16.3% yoy) Financial FY14 Consolidated EBITDA of Rs. 6,724 mio (up 10.6% yoy) Performance • New Hospitals in initial stages of operations reported operating loss of Rs 210 mio in FY14 • AHLL reported an EBITDA loss of Rs. 175 mi
Slide 5: Highlights – (2/2) Capacity, Medical Initiatives
Highlights – (2/2) 50 hospitals with total bed capacity of 8,617 beds as on Mar 31, 2014 • 39 owned hospitals including JVs/ Subsidiaries and associates with 6,684 beds and 11 Capacity Managed hospitals with 1,933 beds. Of the 6,684 owned beds, 5,811beds were operational and had an occupancy of
Slide 6: Contents
Contents • Highlights • Standalone Financial Performance • Consolidated Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs 6
Slide 7: Standalone Financial Performance – Total (1/3)
Standalone Financial Performance - Total - (1/3) ` Mio Q4 FY 13 Q4 FY 14 yoy (%) FY 13 FY 14 yoy (%) Key Highlights Revenue 8,483 9,982 17.7% 33,178 38,616 16.4% Operative Expenses 4,422 5,133 16.1% 17,198 20,019 16.4% Revenues of Rs. 38.616 Employee Expenses 1,324 1,627 22.9% 5,244 6,102 16.4% mi
Slide 8: Standalone Financial Performance – Existing & New Breakup (2/3)
Standalone Financial Performance – Existing & New Breakup - (2/3) ` Mio Healthcare Key Highlights services Existing New (Existing) SAP Standalone Hospitals Standalone Existing Health Care Services LFL (like for like ) revenue growth at 11% FY 14 Revenue 24,437 13,648 38,085 531 38,616 Existing H
Slide 9: Standalone Segment-wise Performance (3/3)
Standalone Segment-wise Performance – (3/3) ` Mio Q4 FY 13 Q4 FY 14 yoy (%) FY 13 FY 14 yoy (%) Revenues from each segment Key Highlights Heathcare Services * 5,627 6,334 12.6% 22,167 24,971 12.6% Stand-alone Pharmacy 2,859 3,649 27.6% 11,017 13,648 23.9% Other Income 91 70 356 225 Revenues at Rs.
Slide 10: Contents
Contents • Highlights • Standalone Financial Performance • Consolidated Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs 10
Slide 11: Consolidated Financial Performance – Total (1/2)
Consolidated Financial Performance – Total - (1/2) ` Mio Q4 FY 13 Q4 FY 14 yoy (%) FY 13 FY 14 yoy (%) Key Highlights Income from Operations 9,019 10,501 16.4% 35,328 41,113 16.4% Add: Share of JVs 599 725 20.9% 2,359 2,730 15.7% Total Revenues 9,618 11,226 16.7% 37,687 43,842 16.3% Revenue growth
Slide 12: Consolidated Financial Performance – Existing & New Breakup (2/2)
Consolidated Financial Performance – Existing & New Breakup - (2/2) ` Mio Total Healthcare Key Highlights serv New AHLL (incl (Existing) SAP Hospitals Munich Cradle) Consol Total healthcare service FY 14 (existing) EBITDA margins Revenue 28,327 13,648 531 607 729 43,842 expanded from 23.2% in FY13
Slide 13: Contents
Contents • Highlights • Standalone Financial Performance • Consolidated Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs 13
Slide 14: Operational Performance – Hospitals
Operational Performance – Hospitals ` Mio Total (5) Chennai cluster Hyderabad cluster Others (1) Significant subs/ JVs/ associates (2) Particulars FY 13 FY 14 Growth yoy FY 13 FY 14 Growth FY 13 FY 14 Growth FY 13 FY 14 Growth FY 13 FY 14 Growth (%) yoy (%) yoy (%) yoy (%) yoy (%) No. of Operating b
Slide 15: Contents
Contents • Highlights • Standalone Financial Performance • Consolidated Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs 15
Slide 16: Operational Performance – Standalone Pharmacy
Operational Performance – Standalone Pharmacy ` Mio Batch Particulars Q4 FY 13 Q4 FY 14 yoy % FY 13 FY 14 yoy % Key Highlights No of Stores 455 434 455 434 Upto FY Revenue/store 2.54 2.98 17.2% 10.33 11.63 12.6% 2008 EBITDA /store 0.14 0.17 0.55 0.66 Batch Revenues at Rs. 13,648 EBITDA Margin % 5.
Slide 17: Contents
Contents • Highlights • Standalone Financial Performance • Consolidated Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs 17
Slide 18: Key Hospital Expansion Plan & Update on Execution
Key Hospital Expansion Plan & Update on Execution Total AHEL's Estimated Share of Strategy for Expansion Project Cost Cost Location CoD* Type of Hospital No of Beds (Rs.mio) (Rs.mio) Focus on owned hospitals Mumbai Cluster – Plan to add 12 hospitals from the current 39 Navi Mumbai FY16 Super Speci
Slide 19: Contents
Contents • Highlights • Standalone Financial Performance • Consolidated Financial Performance • Operational Performance – Hospitals • Operational Performance – Standalone Pharmacy • Update on Projects • Update on non-hospital JVs 19
Slide 20: Update on non-hospital JVs
Update on non-hospital JVs ` Mio Key Highlights Particulars Q4 FY 13 Q4 FY 14 yoy (%) FY 13 FY 14 yoy (%) During FY14, the company Total Income 1,353 1,618 19.6% 4,853 5,937 22.3% achieved a Gross Written Premium (GWP) of Rs. 6,926 mio against a GWP of Rs. 6,200 mio in FY13. EBITDA (19) (101) (13)
Slide 21: Q&A
Q&A 21
Slide 22: Appendix: Basis of Consolidation
Appendix: Basis of Consolidation AHEL Standalone Location Description Chennai Main Chennai Hospital ASH - Chennai Chennai Hospital Tondiarpet - Chennai Chennai Hospital FirstMed - Chennai Chennai Hospital Apollo Children's Hospital Chennai Hospital Apollo Specialty, Vanagaram Chennai Hospital Madura
Slide 23: Hospitals – Understanding Key Operating Metrics
Hospitals – Understanding Key Operating Metrics Description Formula / Calculation Key Driver Number of operating Project execution Operating Beds beds Capital Expenditure x In-patient Bed Days In-patient Bed Days Brand Occupancy Billed Doctor reputation Quality of outcomes Competit
Apollo Hospitals Enterprise — Q4 FY2014 Earnings Presentation on 6ix